Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling

Details for Australian Patent Application No. 2005214286 (hide)

Owner Erasmus Universiteit Rotterdam

Inventors Van der Spek, Petrus Johannes; Valk, Petrus Jacobus Maria; Moorhouse, Michael John; Lowenberg, Bob; Delwel, Hendrik Rudolf

Agent Freehills

Pub. Number AU-A-2005214286

PCT Pub. Number WO2005/080601

Priority 04075570.4 23.02.04 EP

Filing date 23 February 2005

Wipo publication date 1 September 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/080601 Priority application(s): WO2005/080601

17 May 2007 Assignment before Grant

  Erasmus Universiteit Rotterdam The application has been assigned to Erasmus University Medical Center Rotterdam

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214287-Targeted delivery of RNA interference molecules for the treatment of IgEmediated disorders

2005214276-Benzopyran compound useful for the treatment of arrhytmia